FDA Announces Public Advisory Committee Meeting to Discuss Influenza Vaccine Strain Selection

Summary

The Food and Drug Administration (FDA) is hosting a public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) to discuss the selection of influenza virus strains for the 2023 Southern Hemisphere influenza season, and is seeking public comments on the matter.